ICU Medical, Inc. (NASDAQ:ICUI) is among the top gainers of the stock market today, skyrocketing 9.59% or (18.82 points) to $215.1 from its previous close of $196.28. Does this growth mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 299693 contracts so far this session. ICUI shares had a relatively better volume day versus average trading capacity of 179.41 thousand shares, but with a 19.21 million float and a 6.06% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for ICUI stock indicates that the average analyst price target is $201.5 per share. This means the stock has a potential decrease of -6.32% from where the ICUI share price has been trading recently.
During the recent trading session for ICU Medical, Inc. (NASDAQ:ICUI), the company witnessed their stock rise $29.46 over a week and surge $27.28 from the price 20 days ago. When compared to their established 52-week high of $259.72, the high they recorded in their recent session happens to be higher. Their established 52-week high was attained by the company on 01/08/19. The recent low of $148.89 stood for a -17.18% since 10/16/19, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 0.91 is also allocated to the stock. Since the beta is less than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.
Looking at the current readings for ICU Medical, Inc., the two-week RSI stands at 75.25. This figure suggests that ICUI stock, for now, is oversold, meaning that the shares are not stable in terms of price movement. The stochastic readings, on the other hand, based on the current ICUI readings is similarly very revealing as it has a stochastic reading of 88.59% at this stage. This figure means that ICUI share price today is being oversold.
Technical chart claims that ICU Medical, Inc. (ICUI) would settle between $198.15/share to $200.03/share level. However, if the stock price goes below the $193.64 mark, then the market for ICU Medical, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $191.01 for its downside target. The stock is currently in the green zone of MACD, with the indicator reading 10.25. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.
Analysts at Raymond James lowered their recommendation on shares of ICUI from Strong Buy to Outperform in their opinion released on August 08. KeyBanc Capital Mkts, analysts launched coverage of ICU Medical, Inc. (NASDAQ:ICUI) stock with a Sector Weight recommendation, according to their flash note issued to investors on October 17. Analysts at Sidoti lowered the stock to a Neutral call from its previous Buy recommendation, in a research note that dated back to June 20.
ICUI equity has an average rating of 2.67, with the figure leaning towards a bullish end. 3 analysts who tracked the company were contacted by Reuters. Amongst them, 2 rated the stock as a hold while the remaining 1 were split even though not equally. Some analysts rate the stock as a buy or a strong buy while no rated it as a sell. 1 analysts rated ICU Medical, Inc. (NASDAQ:ICUI) as a buy or a strong buy while not a single analyst advised that investors should desist from purchasing the stock or sell them if they already own the company’s stock.
Moving on, ICUI stock price is currently trading at 28.04X forward 12-month Consensus EPS estimates, and its P/E ratio is 57.9 while for the average stock in the same group, the multiple is 63.1. ICU Medical, Inc. current P/B ratio of 3 means it is trading at a discount against its industry’s 4.4.
ICU Medical, Inc. (ICUI)’s current-quarter revenues are projected to climb by nearly -13.1% to hit $295700, based on current consensus estimate. The firm’s full-year revenues are expected to expand by over -14.7% from $1.4 billion to a noteworthy $1.19 billion. At the other end of the current quarter income statement, ICU Medical, Inc. is expected to see its adjusted earnings surge by roughly -21.3% to hit $1.63 per share. For the fiscal year, ICUI’s earnings are projected to climb by roughly -10.9% to hit $7.88 per share.